Introduction Early, accurate diagnosis is fundamental in the management of patients with ventilator-associated pneumonia (VAP). The aim of this qualitative review was to compare various criteria of diagnosing VAP in the intensive care unit (ICU) with a special emphasis on the value of clinical diagnosis, microbiological culture techniques, and biomarkers of host response.
Introduction
Ventilator-associated pneumonia (VAP) is common in the intensive care unit (ICU), affecting 8 to 20% of ICU patients and up to 27% of mechanically ventilated patients [1] . Several risk factors have been reported to be associated with VAP, including the duration of mechanical ventilation, and the presence of chronic pulmonary disease, sepsis, acute respiratory distress syndrome (ARDS), neurological disease, trauma, prior use of antibiotics, and red cell transfusions [2] . Mortality rates in patients with VAP range from 20 to 50% and may reach more than 70% when the infection is caused by multi-resistant and invasive pathogens [1] [2] [3] . The incidence of VAP-attributable mortality is difficult to quantify due to the possible confounding effect of associated conditions, but VAP is thought to increase the mortality of the underlying disease by about 30% [3] . VAP is also associated with considerable morbidity, including prolonged ICU length of stay, prolonged mechanical ventilation, and increased costs of hospitalization [3, 4] . ARDS = Acute respiratory distress syndrome; BAL = Bronchoalveolar lavage; CFU = Colony forming units; CPIS = Clinical pulmonary infection score; CRP = C-reactive protein; EF = Elastin fiber; ICU = Intensive care unit; NNIS = National Nosocomial Infection Surveillance; pBAL = Protected bronchoalvolar lavage; PCT = Procalcitonin; PSB = Protected specimen brush; SIRS = Systemic inflammatory response syndrome; sTREM = Soluble triggering receptor expressed on myeloid cells; TBA = Tracheobronchial aspirate; VAP = Ventilator-associated pneumonia.
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Delayed diagnosis and subsequent delay in initiating appropriate therapy may be associated with worse outcomes in patients with VAP [1, 5, 6] ; on the other hand, an incorrect diagnosis may lead to unnecessary treatment and subsequent complications related to therapy [1, 7, 8] . Early, accurate diagnosis is, therefore, fundamental in the management of patients with VAP [9] . Several criteria have been proposed for diagnosing VAP in clinical settings, including clinical manifestations, imaging techniques, methods to obtain and interpret bronchoalveolar specimens, and biomarkers of host response. Due to the lack of an acceptable gold standard, the accuracy of these methods in diagnosing VAP is controversial.
The aim of this qualitative review was, therefore, to compare various criteria for diagnosing VAP in the ICU with a special emphasis on the value of clinical diagnosis, microbiological culture techniques, and biomarkers of host response.
Materials and methods
We performed a MEDLINE search using the keywords 'ventilator associated pneumonia' AND 'diagnosis'. Our search was limited to human studies published between January 1966 and June 2007. The abstracts of all articles were used to confirm our target population (patients with VAP) and the corresponding full-text articles were reviewed for the presence of data comparing a diagnostic test to a 'gold-standard'. Only studies of at least 25 adult patients were included. Two investigators (AR and NC) independently identified the eligible literature. Predefined variables were collected, including year of publication, study design (prospective/retrospective), number of patients included, and disease group. Any inconsistencies between the two investigators in interpretation of data were resolved by consensus. To avoid publication bias, abstracts and full articles were eligible. We also reviewed the bibliographies of available studies for other potentially eligible studies. Of 572 articles fulfilling the initial search criteria, 159 articles were chosen for detailed review of the full text. A total of 64 articles fulfilled the inclusion criteria and were included in our review.
Results

Accuracy of the clinical diagnosis of VAP
There is no single clinical manifestation that can be used alone to diagnose VAP. Chest radiology, although very sensitive, is typically nonspecific [10, 11] . Wunderink et al. [12] showed that no roentgenographic sign correlates well with pneumonia in mechanically ventilated patients. Lobar or subsegmental atelectasia, ARDS, alveolar hemorrhage, and/or infarction may be mistaken for pneumonia [12] . Other clinical signs (fever, leukocytosis or pulmonary manifestations) have intermediate predictive values [11, 13] . The clinical diagnosis of VAP has, therefore, traditionally been made by the association of a new or progressive consolidation on chest radiology plus at least two of the following variables: fever greater than 38°C, leukocytosis or leukopenia, and purulent secretions. These criteria were proposed by Johanson et al. [14] (Table 1) , and compared to immediate post-mortem lung biopsies by Fàbregas et al. [11] . The sensitivity was only 69% and specificity not better than 75% (accuracy of 72%). An increase (or decrease) in the number of clinical criteria, can increase (or decrease) the specificity, but at the cost of sensitivity. Despite this relatively low accuracy, these criteria were recommended by the American Thoracic Society Consensus Conference on VAP [1] .
Combinations of various criteria to establish a diagnosis in patients with VAP have been suggested and validated ( Table  1 ). The National Nosocomial Infection Surveillance (NNIS) system was developed in the 1970s by the Centers for Disease Control as a tool to describe the epidemiology of hospital-acquired infections and to produce aggregated rates of infection suitable for inter-hospital comparison, but was never compared to pathological results. The NNIS system was compared to bronchoalveolar lavage (BAL) fluid cultures in 292 trauma patients and had a sensitivity of 84% and a specificity of 69% [15] . More recently, the Clinical Pulmonary Infection Score (CPIS) was proposed by Pugin et al. [16] , based on six variables (fever, leukocytosis, tracheal aspirates, oxygenation, radiographic infiltrates, and semi-quantitative cultures of tracheal aspirates with Gram stain) [16] . The original description showed a sensitivity of 93% and specificity of 100%, but this study included only 28 patients and the CPIS was compared to quantitative culture of BAL fluid using a 'bacterial index' defined as the sum of the logarithm of all bacterial species recovered, which is not considered an acceptable gold standard for the diagnosis of VAP. Compared to pathological diagnosis, CPIS had a moderate performance with a sensitivity between 72 and 77% and specificity between 42 and 85% [11, 17] . Likewise, CPIS was not sufficiently accurate compared to a BAL fluid-established diagnosis with sensitivity between 30 and 89% and specificity between 17 and 80% [17] [18] [19] [20] [21] [22] (Table 2) . Luyt et al. [19] studied 201 mechanically ventilated patients in whom strict bronchoscopic criteria were applied to diagnose or exclude pneumonia. The CPIS assessed at baseline was calculated retrospectively and did not differ significantly for patients with or without VAP. The potential use of CPIS as the sole means to diagnosis VAP was also evaluated in 158 trauma patients [18] . The average CPIS was similar between patients with systemic inflammatory response syndrome (SIRS) (BAL < 10 5 colony forming units(CFU)/ml) and those with VAP (BAL > 10 5 CFUml) with a sensitivity of 61% and specificity of 43%. In 28 patients with burn injuries, Pham et al. [23] found that CPIS had a sensitivity of 30% and specificity of 80% in diagnosing VAP compared to quantitative BAL fluid culture.
A major limitation of the literature validating CPIS for diagnosing VAP is that BAL culture is not a true gold standard [11, 13, 17, [24] [25] [26] [27] [28] . In addition, the calculation of CPIS was modified by some authors and different cutoff points were used to diagnose VAP [19, 20] . Importantly, the inter-observer Table 1 Clinical criteria used in diagnosing ventilator-associated pneumonia Johanson (Tables  2, 3 , 4, 5, 6). In a study by Torres et al. [26] , quantitative cultures were obtained through BAL (bacterial count = 10 4 CFU), protected BAL (pBAL) (10 4 ), protected specimen brush (PSB) (10 3 ) and tracheobronchial aspirate (TBA) (10 5 ) and were compared to five different histological and microbiological references [26] . Sensitivities for diagnosis of VAP ranged from 22% to 50% when only histologic reference tests were used, whereas specificity ranged from 45% to 100%. When lung histology of guided or blind specimens and microbiology of lung tissue were combined [11, 13, 16, [24] [25] [26] [27] [28] [29] [30] [31] , all quantitative diagnostic techniques achieved relatively higher, but still limited, diagnostic yields (sensitivity range 19% to 87%; specificity range 31% to 100% Pathology + Culture • Johanson criteria (2 items): sens = 69%, spec = 75%.
• Any Johanson criteria: Chest Rx: sens = 92%, spec = 33%; leukocytosis: sens = 77%, spec = 58%; fever: sens = 46%, spec = 42%; purulent secretions: sens = 69%, spec = 42%
• CPIS: sens = 77%, spec = 42%.
• TBA sens = 69%, spec = 92%.
• pBAL sens = 39%, spec = 100%.
• BAL sens = 77%, spec = 58%.
• PSB sens = 62%, spec = 75%.
• • CPIS: sens = 93%, spec = 100%, r = 84% (CIPS and mini-BAL), r = 76% (CPIS and BAL)
• Mini-BAL: sens = 73%, spec = 96% CPIS = clinical pulmonary infection score; TBA = tracheobronchial aspirate; PSB = protected specimen brush; pBAL = protected BAL or 'mini-BAL'; BAL = bronchoalveolar lavage; sens = sensitivity; spec = specificity; QtC = quantitative culture; BBS = blind bronchial sampling; SIRS = systemic inflammatory response syndrome; PPV = positive predictive value; NPV = negative predictive value; CE = clinical estimate; NNIS = National nosocomial infection surveillance system; BI = bacterial index; ICU = intensive care unit; *retrospective; **consecutive; # convenient.
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ologically confirmed diagnosis of VAP, BAL (104) had a sensitivity between 19 and 83% and specificity between 45 and 100%, PSB (103) a sensitivity between 36 and 83% and specificity between 50 and 95%, pBAL (104) a sensitivity between 39 and 80% and specificity of 66 to100%, and TBA (105) a sensitivity between 44 to 87% and specificity between 31 to 92% (Table 3 ) [10, 11, 13, 17, [24] [25] [26] [27] [28] [29] [30] . Torres et al. [26] demonstrated that prior antibiotic use considerably decreased the sensitivity of the cultures of BAL samples. Kirtland et al. [27] and Rouby et al. [30] reported that the microorganism Table 3 Studies comparing quantitative cultures with pathology Pathology + Culture • TBA: sens = 50%, spec = 67%.
• PSB: sens = 67%, spec = 75%.
• pBAL: sens = 63%, spec = 83%.
• BAL: sens = 83%, spec = 68%. (2): sens = 69%, spec = 75%.
• Any Johanson criteria: Chest Rx: sens = 92%, spec = 33%; leukocytosis: sens = 77%, spec = 58%; fever: sens = 46%, spec = 42%; purulent secretions: sens = 69%, spec = 42%.
• TBA: sens = 69%, spec = 92%.
• pBAL: sens = 39%, spec = 100%.
• BAL: sens = 77%, spec = 58%.
• PSB: sens = 62%, spec = 75%.
• QtC increased little to clinical diagnosis accuracy.
Papazian, 1997, # [29] Mixed ICU, 28 pts Gram & ICO Pathology + Culture • BBS Gram stain: sens = 56%, spec = 73%.
• mini-BAL Gram Stain: sens = 44%, spec = 87%.
• BAL Gram stain: sens = 56%, spec = 100%.
• BBS ICO (>10%): sens = 56%, spec = 40%.
• Mini-BAL ICO (>5%): sens = 67%, spec = 53%.
• BAL ICO (>4%): sens = 56%, spec = 40%. • pPSB: sens = 30%, spec = 81%.
• PSB: sens = 44%, spec = 81%.
• BAL: sens = 65%, spec = 63%.
• >50% neutrophils in BAL: sens = 100%. • TA (10 6 ): sens = 50%, spec = 85%.
• PSB (10 3 ): sens = 57%, spec = 88%.
• BAL (10 4 ): sens = 47%, spec = 100%.
• ICO (any%): sens = 36%, spec = 100%. • ICO (≥ 5%) compared to BAL: PPV = 57%, NPV = 8 3%.
• Mini-BAL: sens = 22%, spec = 100%.
• BAL: sens = 45%, spec = 55%. • BBS (10 4 ): sens = 83%, spec = 80%.
• mini-BAL (10 3 ): sens = 67%, spec = 80%.
• BAL (10 4 ): sens = 58%, spec = 95%.
• PSB (10 3 ): sens = 42%, spec = 95%. • Clinical data: fever: sens = 55%, spec = 58%; purulent secretions: sens = 83%, spec = 33%; Rx infiltrate: sens = 78%, spec = 42%.
• Pulmonary biopsy culture (≥10 3 ): sens = 40%, spec = 45%.
• Quantitative cultures: TBA: sens = 44%, spec = 48%; PSB: sens = 36%, spec = 50%; BAL: sens = 50%, spec = 45%. ICU = intensive care unit; BAL = bronchoalveolar lavage; sens = sensitivity; spec = specificity; TBA = tracheobronchial aspirate; PSB = protected specimen brush; pBAL = protected BAL or 'mini-BAL'; CPIS = clinical pulmonary infection score; QtC = quantitative culture; ICO = intracellular organism; BBS = blind bronchial sampling; TA = tracheal aspiration; PPV = positive predictive value; NPV = negative predictive value; * = retrospective; ** = consecutive; # convenient Table 4 Studies comparing quantitative cultures using various techniques or cutoff points • TA: sens = 77%, spec = 81%.
• bPTC: sens = 77%, spec = 97%.
• PTC: sens = 77%, spec = 94%.
Davis, 2005, # [42]
Trauma ICU, 155 pts Gram (BAL) CDC + BAL (10 5 ) • Gram (BAL): sens = 88% (any organism).
• Gram (BAL): sens = 73%, spec = 49%; PPV = 78%, NPV = 42%, accuracy = 65% (Gram-negative).
• Gram (BAL): sens = 87%, spec = 59%; PPV = 68%, NPV = 83%, accuracy = 74% (Gram-positive). • TA and PSB: sens = 91%, spec = 72%; PPV = 75%, NPV = 90%.
• TA and BAL: sens = 91%, spec = 75%; PPV = 78%, NPV = 90%. • mini-PSB and BAL: concordance = 84%.
• mini-PSB and PSB: concordance = 85%.
Pugin, 1991, ** [16] Surgical ICU, 28 pts,
• CPIS: sens = 93%, spec = 100%, r = 84% (CIPS and mini-BAL), r = 76% (CPIS and BAL).
• Mini-BAL: sens = 73%, spec = 96%.
Jourdain, 1995, ** [36] Mixed ICU, 39 pts TA (10 3 to 10 7 ) P S B ( 1 0 3 ) and ICO (≥ 5%)
• TA (10 3 ): sens = 90%, spec = 26%, accuracy = 47%.
• TA (10 4 ): sens = 84%, spec = 40, accuracy = 54%.
• TA (10 5 ): sens = 79%, spec = 66%, accuracy = 70%.
• TA (10 6 ): sens = 68%, spec = 84%, accuracy = 79%, correlation = 40% (TA and PSB).
• TA (10 7 ): sens = 21%, spec = 92%, accuracy = 68%. • BAL (10 3 ): sens = 89%, spec = 79%, PPV = 76%, NPV = 90%.
• BAL (10 4 ): sens = 89%, spec = 100%, PPV = 100%, NPV = 92%.
• ICO (≥ 2%): = 78%, spec = 88%, PPV = 82%, NPV = 84%.
• ICO (≥ 5%): = 67%, spec = 96%, PPV = 92%, NPV = 79%.
• ICO (≥ 7%): = 67%, spec = 100%, PPV = 100, NPV = 80%.
• ICO for Pseudomonas: lower sens.
• Previous antibiotic treatment decreased sens.
El-Ebiary, 1993, ** [40] Medical ICU, 102 pts TA, PSB and BAL Clinical ad hoc • TA (10 5 ): sens = 70%, spec = 72%, accuracy = 71%.
• PSB (10 3 ): sens = 60%, spec = 93, accuracy = 64%.
• BAL (10 4 ): sens = 57%, spec = 87%, accuracy = 67%.
Elatrous, 2004, ** [33] Medical ICU, 100 pts, TA (10 2 to 10 6 ) P T C ( 1 0 6 ) • T A ( 1 0 2 ): sens = 96%, spec = 66%.
• TA (10 3 ): sens = 94%, spec = 66%.
• TA (10 4 ): sens = 92%, spec = 85%, k = 0,78.
• TA (10 5 ): sens = 84%, spec = 90%.
• TA (10 6 ): sens = 44%, spec = 94%.
identified in quantitative culture from a transtracheal method frequently does not correlate well with the culture obtained from pathological samples. In addition, several studies [59] [60] [61] have challenged the reliability of quantitative cultures. Timsit et al. [56] reported moderate intra-individual variability in comparing two consecutive PSB procedures performed in the same lung. Likewise, Gerbeaux et al. [57] performed two BAL procedures in the same lung area to distinguish between the presence and absence of bacterial pneumonia and showed a repeatability of only 75%. Butler et al. [58] compared the results of blind PSB sampling from the contralateral lung and PSB from the site of the observed infiltrates; the concordance rate between the two samples was only 53%. • Gram (10 fields) vs PSB: sens = 74%, spec = 94%.
• Gram (10 fields) vs PTC: sens = 81%, spec = 100%.
• PSB: correlation between morphology and culture: sens = 54%, spec = 86%.
• bPTC: correlation between morphology and culture: sens = 69% and spec = 89%. • Mini-BAL: sens = 74%, spec = 70%, PPV = 17%, NPV = 96%.
• BAL: sens = 76%, spec = 71%, PPV = 35%, NPV = 93%.
• PSB: sens = 68%, spec = 86%, PPV = 54%, NPV = 95%.
• CPIS > 7: sens = 85%, spec = 91%, PPV = 61%, NPV = 96%.
• BI: sens = 62%, spec = 53%.
Allaouchiche, 1999, ** [51] Mixed ICU, 118 pts,
PSB (10 3 ) • ICO: sens = 86%, spec = 78%, PPV = 68%, NPV = 91%, k = 0.616, concordance = 81.5%.
• Gram stain: sens = 90%, spec = 73%, PPV = 64%, NPV = 91%, k = 0.58, concordance = 79.4%.
• Correlation between morphology and culture: complete = 51%, partial = 39.2%, no correlation = 9.8%. Clin ad hoc • ICO: sens = 71% (no antibiotics), 50% (current antibiotics), 67% (recent antibiotics).
• PSB: sens = 88% (no antibiotics), 77% (current antibiotics), 40% (recent antibiotics).
• BAL: sens = 71% (no antibiotics), 83% (current antibiotics), 38% (recent antibiotics). • pBAL: sens = 87%, spec = 91%, PPV = 87%, NPV = 91%.
• ICO: sens = 75%, spec = 98%, PPV = 96%, NPV = 86%. • PSB 1: sens = 67%, spec = 94%.
• PSB 2: sens = 54%, spec = 94%.
Gerbeaux, 1998, ** [57] Mixed ICU, 44 pts BAL 1 BAL 2 (30 minutes interval)
• BAL 1-BAL2 repeatability = 75% with no bias, agreement = 47%. ICU = intensive care unit; TA = tracheal aspiration; BAL = bronchoalveolar lavage; sens = sensitivity; spec = specificity; bPTC = blinded protected telescoping catheter; PTC = protected (plugged) telescoping catheter; ICO = intracellular organism; CDC = center for disease control; PPV = positive predictive value; NPV = negative predictive value; ClEvol: clinical evolution; PSB = protected specimen brush; CPIS = clinical pulmonary infection score; BI = bacterial index; ATS = American Toracic Society; vs = versus; BDPB = bronchoscope-directed protected brushings; BPB = blind protected brushing via endotracheal tube; *retrospective; **consecutive; # convenient.
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Studies comparing quantitative cultures using various techniques or cutoff points (page number not for citation purposes)
The rate of positive blood cultures in VAP ranges from 8 to 20% [62, 63] . In 162 patients with suspected VAP, Luna et al. [64] showed that the sensitivity of blood cultures in 90 patients with VAP confirmed by BAL was only 26% and, in many cases, the bacteria isolated in the blood cultures probably had an extrapulmonary source. Blood cultures were also positive in 5 of 72 patients without VAP (6.9%).
Since bacteriological cultures require some days for the results to be available at the bedside, several studies have investigated the value of cytological characteristics of the available bronchoalveolar specimens in diagnosing VAP. These characteristics include the number of inflammatory cells and Gram stains. The rapid availability of cytological data has been shown to be useful in initial therapeutic decisions in patients with suspected VAP [42, 46, 47, 50, 51, [65] [66] [67] . The presence of more than 2% inflammatory cells had a sensitivity of 75% to 86% and a specificity of 78% to 98% in diagnosing the first episode of VAP (Table 6 ). Other studies [46, 49, 50, 68] investigated other cutoff values and reported contradictory results. Prior antibiotic use was also shown to influence the number of inflammatory cells in patients with VAP [45, 54] . Infections with Pseudomonas aeruginosa were also shown to decrease the sensitivity of cytological data in diagnosing VAP compared with other bacteria [49] . The presence of bacteria in Gram stains of bronchoalveolar specimens had a sensitivity of 44% to 90% and specificity of 49% to 100% in identifying patients with VAP (Table 6 ). Davis et al. [42] showed that the accuracy of Gram stains was slightly better for Gram-positive than for Gram-negative microorganisms.
Although the presence of bacteria on Gram stain appears to have a reasonable accuracy compared to quantitative culture available two to three days later, the agreement between the two methods ranges from 79.4 to 86% (Table 6 ).
In summary: Bacteriologic data do not increase the accuracy of diagnosis when compared to clinical diagnosis. Quantitative cultures obtained by different methods, including BAL, pBAL, PSB or TBA seem to be fairly equivalent in diagnosing VAP. Blood cultures are relatively insensitive to diagnose pneumonia. The rapid availability of cytological data, including inflammatory cells and Gram stains, may be useful in initial therapeutic decisions in patients with suspected VAP but may be influenced by prior antibiotic use and the infecting microorganism.
Biomarkers and VAP diagnosis
Many biological markers have been studied in an effort to improve the rapidity and performance of current diagnostic procedures in VAP. When the anatomical and mechanical defense mechanisms that prevent microorganisms from reaching alveoli are overwhelmed, a complex host response develops [1] . Microbial products activate alveolar macrophages, which release multiple endogenous mediators locally. Among these mediators, tumor necrosis factor alpha, interleukin-1β, and other cytokines are increased in various types of pulmonary infections and thus have potential prognostic implications. However, there is no cutoff value for such mediators that could be used to diagnose pneumonia. Several biomarkers have been investigated for diagnosing VAP ( Table 7) . The presence of elastin fiber (EF), a marker of parenchymal lung destruction, in tracheal secretion has been proposed to differ- Clinical (ad hoc)
• TA (10 6 CPIS ≥6
• BAL: sens = 90%.
• PSB: sens = 83%.
• TA (10 5 ): sens = 90%.
• TA (10 6 entiate colonization from infection of the lung. However, the presence of EF in tracheal aspirates had low sensitivity (32%) and only reasonable specificity (72%) in diagnosing VAP [69] . In 22 patients with ARDS, Shepherd et al. [70] found that EF had a sensitivity of only 40% in diagnosing VAP. This may be due to the fact that EF correlates with lung destruction, more than infection per se.
Procalcitonin (PCT) and C-reactive protein (CRP) measurements have been shown to improve the clinical accuracy in identifying patients with SIRS caused by infection from SIRS of other causes. Serum PCT levels had a better performance than alveolar PCT concentrations, with a sensitivity of 41% and a specificity of 100% [71] . In patients after cardiac arrest and return of spontaneous circulation, PCT had a sensitivity of 100% and a specificity of 75% for the diagnosis of VAP [72] .
Póvoa et al. showed that CRP (>9.6 mg/dl) had a good accuracy for VAP, with sensitivity of 87% and a specificity of 88% in a population of general ICU patients [73] . In addition, in 47 patients with microbiologically confirmed VAP, high CRP levels were associated with poor outcome [74] .
The detection of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in BAL fluid may be useful in establishing or excluding a diagnosis of bacterial or fungal pneumonia. Gibot et al. [75] studied 148 patients with suspected pneumonia and measured sTREM-1 in their BAL fluid. These authors showed that the presence of sTREM by itself was more accurate than any clinical findings or laboratory values in identifying the presence of bacterial or fungal pneumonia. Questions about the lack of a gold standard definition for VAP may have hampered classification of some of patients. In 28 (10 5 ) • Gram (BAL): sens = 88% (any organism).
• Gram (BAL): sens = 73%, spec = 49%, PPV = 78%, NPV = 42%, accuracy = 65% (Gram-negative).
• Gram (BAL): sens = 87%, spec = 59%, PPV = 68%, NPV = 83%, accuracy = 74% (Gram-positive). • Gram stain (10 fields) vs PSB: sens = 74%, spec = 94%.
• Gram stain (10 fields) vs PTC: sens = 81%, spec = 100%.
• Gram (50 fields): slight increase in spec, decrease in sens • Morphology and PSB culture: sens = 54%, spec = 86%.
• Morpholgy and bPTC culture: sens = 69%, spec = 89%. PSB (10 3 ) • ICO: sens = 86%, spec = 78%, PPV = 68%, NPV = 91%, k = 0.616, concordance 81.5%.
• Gram stain: sens = 90%, spec = 73%, PPV = 64%, NPV = 91%; k = 0.58, concordance 79.4%.
• Correlation between morphology and culture: complete: 51%, partial: 39.%, no correlation: 9.8%. • ICO (≥ 5%) compared to BAL: PPV = 57%, NPV = 83%.
• BAL: sens = 45%, spec = 55%. Clinical ad hoc • BAL: sens = 87%, spec = 100%.
• PSB: sens = 75%, spec = 100%.
• ICO (>4%): sens = 62%, spec = 100%. critically ill mechanically ventilated patients, Determann et al. [76] reported an increase in sTREM-1 levels in non-directed BAL fluid obtained from patients who developed VAP (n = 9) in contrast to those who did not. A cutoff value for BAL fluid sTREM-1 levels of 200 pg/ml had a sensitivity of 75% and specificity of 84% in diagnosing pneumonia.
The value of endotoxin measurements in BAL fluid was also investigated, as approximately 70% of cases of VAP are caused by Gram-negative bacteria. Flanagan et al. [77] reported an increased concentration of endotoxin in bronchoscopic BAL and non-directed BAL fluid of patients with VAP. An endotoxin concentration of 6 EU/ml yielded the optimal operating characteristics (sensitivity of 81% and specificity of 87%). In 40 samples of BAL fluid from patients with multiple trauma requiring prolonged mechanical ventilation, Pugin et al. [78] showed a relation between the concentration of endotoxin in lavage fluid and the quantity of Gram-negative bacteria. An endotoxin level greater than or equal to 6 EU/ml distinguished patients with Gram-negative bacterial pneumonia from colonized patients, and from those with pneumonia due to Gram-positive cocci.
The studies evaluating the value of the previously mentioned biomarkers are limited by the lack of a gold standard used to diagnosis VAP. EF and sTREM-1 were compared to clinical diagnosis ad hoc [75, 76] , PCT was compared to mini-BAL [71] , and CRP to Johanson criteria [73] .
In summary: CRP, PCT, and sTREM are promising biomarkers for diagnosing VAP, while EF and endotoxin concentrations are of limited value. Further studies are needed to fully determine the diagnostic accuracy of these and other biomarkers.
Discussion
Evaluating the performance of various diagnostic tests in patients with suspected VAP is challenging. The absence of a good gold standard for comparison is the main limiting factor in assessing these tests. Establishing a diagnosis of VAP, based on pathology or histology plus culture of the lung tissue, has a considerable degree of uncertainty, however, it is considered the best available gold standard [8] . Pathologic examination of lung tissue is not a perfect gold standard because patients who die are not representative of all patients with VAP. Moreover, many patients die after some days of antibiotic administration, which may alter results of bacteriologic analysis. In addition, pathology or tissue cultures may include nondiseased lung tissue leading to false negative results, and diagnostic criteria based on pathologic examination of lung tissue are not well defined [27, 79] . Fabregas et al. [79] found that the histology and microbiology of post-mortem lung biopsies were poorly correlated, challenging the value of histological examination of lung tissue in diagnosing VAP.
The etiology of VAP probably involves microaspiration of secretions accumulating above the cuff of endotracheal tube [80] . These foci of microinfection may remain localized causing local bronchiolitis without clinically relevant pneumonia or proceed to develop into micro-or macro-bronchopneumonia. The multifocal, heterogeneous nature of VAP is one of the reasons why it is so difficult to establish a diagnosis of VAP. Biopsy specimens can miss the area of active disease. Alternatively, positive results may represent an area of clinically silent early bronchiolitis or resolving bronchial pneumonia. Likewise, cultures can miss the area of active disease (yielding false-negative results) or can detect clinically benign areas of bacterial colonization (yielding false positive results). In addition, the many antibiotics given to critically ill patients may decrease the diagnostic yield of bacterial cultures [24, 79] . AUC: area under the curve; ICU = intensive care unit; CRP = C-reactive protein; sens = sensitivity; spec = specificity; sTREM-1 = soluble triggering receptor expressed on myeloid cells; BAL = bronchoalveolar lavage; PCT = procalcitonin; EF = elastin fiber; NBLF = non-directed bronchial lavage fluids; EU = endotoxin units; *retrospective; **consecutive; # convenient.
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Associated cardiorespiratory comorbidities are another source of bias in diagnosing VAP. Autopsies of ventilated patients with suspected pneumonia frequently reveal a substantial burden of alternative or coexisting pulmonary diseases that can also cause fever, impaired gas exchange, increased secretions, and radiographic opacities. These other conditions include thromboembolic disease, hemorrhage, diffuse alveolar damage, fibrosis, atelectasia, carcinoma, lymphoma, and others [11, 12, 24, 27, 28] . The high prevalence of coexisting pulmonary diseases in ventilated patients further complicates attempts to clinically diagnose VAP.
The major limitation of the clinical approach to diagnosis is that it consistently leads to more antibiotic therapy than when therapy decisions are based on the findings of invasive lower respiratory tract samples. The clinical approach is overly sensitive, and patients can be treated for pneumonia when another noninfectious process is responsible for the clinical findings.
As none of the available diagnostic tests, performed alone, can provide an accurate diagnosis of VAP, a diagnostic strategy incorporating several criteria seems to be a good compromise.
On the basis of clinical data, patients with clinical suspicion of VAP should be further evaluated by imaging procedures, bacteriological cultures, and biomarkers ( Figure 1 ). [82] of four randomized studies with a total of 628 patients showed that invasive strategies for the diagnosis of VAP did not alter mortality. In a recent multicenter trial, Heyland et al. [83] randomized 740 patients who were receiving mechanical ventilation and who had suspected VAP after 4 days in the ICU to undergo either BAL with quantitative culture of the BAL fluid or endotracheal aspiration with non-quantitative culture of the aspirate. Empirical antibiotic therapy was initiated in all patients until culture results were available, at which point a protocol of targeted therapy was used for discontinuing or reducing the dose or number of antibiotics, or for resuming antibiotic therapy to treat a pre-enrollment condition if the culture was negative. There was no significant difference in outcomes or the use of antibiotics. The most likely explanation for this lack of effect on outcome is that prompt adequate initial antimicrobial coverage is the crucial issue affecting survival. Inappropriate or inadequate treatment refers to the use of anti-
Figure 1
Summary of the management strategies for a patient with suspected hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), or healthcare-associated pneumonia (HCAP) Summary of the management strategies for a patient with suspected hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), or healthcare-associated pneumonia (HCAP). The decision about antibiotic discontinuation may differ depending on the type of sample collected (PSB, BAL, or endotracheal aspirate), and whether the results are reported in quantitative or semiquantitative terms. From [1] (with permission).
biotics with either limited or no in vitro activity against the microorganism causing the infection. Since invasive sampling for suspected VAP does not directly affect the initial antibiotic prescription, it is not surprising that it does not alter mortality.
Because of the nature of the technology, the culture results from bronchoscopy become available only after the crucial period when the clinician can intervene to maximal effect [82] .
Conclusion
Clinical criteria, used in combination, may be helpful in diagnosing VAP; however, the considerable inter-observer variability and the moderate performance should be taken into account. Bacteriologic data do not increase the accuracy of diagnosis as compared to clinical diagnosis. Quantitative cultures obtained by different methods, including BAL, pBAL, PSB or TBA seem to be rather equivalent in diagnosing VAP. Blood cultures are relatively insensitive to diagnose pneumonia. The rapid availability of cytological data, including inflammatory cells and Gram stains, may be useful in initial therapeutic decisions in patients with suspected VAP. CRP, PCT, and sTREM are promising biomarkers in diagnosing VAP. An integrated approach should be followed in diagnosing and treating patients with VAP, including early antibiotic therapy and subsequent rectification according to clinical response and results of bacteriologic cultures.
Key messages
• Clinical criteria, used in combination, may be helpful in diagnosing VAP, however, the considerable interobserver variability and the moderate performance should be taken in account.
• Bacteriologic data do not increase the accuracy of diagnosis as compared to clinical diagnosis. Quantitative cultures obtained by different methods, including BAL, pBAL, PSB or TBA seem to be rather equivalent in diagnosing VAP.
• The rapid availability of cytological data, including inflammatory cells and Gram stains, may be useful in initial therapeutic decisions in patients with suspected VAP.
• CRP, PCT, and sTREM are promising biomarkers in diagnosing VAP.
• An integrated approach should be followed in diagnosing and treating patients with VAP, including early antibiotic therapy and subsequent rectification according to clinical response and results of bacteriologic cultures.
